Truist Financial Corp Emergent Bio Solutions Inc. Transaction History

Truist Financial Corp

$66.7 Billion
Q2 2025

A detailed history of Truist Financial Corp transactions in Emergent Bio Solutions Inc. stock. As of the latest transaction made, Truist Financial Corp holds 33,500 shares of EBS stock, worth $430,140. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,500

Previous 335,429 90.01%

Holding current value

$430,140

Previous $1.63 Million 86.93%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 18, 2025	BUY	$4.26 - $6.94 $113,350 - $184,659	26,608 Added 7.93%	362,037 $2.31 Million
Q1 2025 Apr 29, 2025	BUY	$4.66 - $11.66 $1.17 Million - $2.92 Million	250,236 Added 293.73%	335,429 $1.63 Million
Q4 2024 Jan 31, 2025	SELL	$7.72 - $11.97 $455,503 - $706,265	-59,003 Reduced 40.92%	85,193 $814,000
Q3 2024 Nov 13, 2024	BUY	$5.72 - $14.77 $72,472 - $187,135	12,670 Added 9.63%	144,196 $1.2 Million
Q2 2024 Aug 20, 2024	BUY	$1.86 - $6.98 $26,709 - $100,232	14,360 Added 12.26%	131,526 $897,000
Q1 2024 May 10, 2024	BUY	$1.5 - $3.41 $5,250 - $11,935	3,500 Added 3.08%	117,166 $296,000
Q4 2023 Feb 02, 2024	BUY	$1.82 - $3.16 $6,542 - $11,360	3,595 Added 3.27%	113,666 $272,000
Q3 2023 Nov 14, 2023	BUY	$3.17 - $7.91 $348,925 - $870,661	110,071 New	110,071 $374,000
Q2 2021 Aug 16, 2021	SELL	$56.61 - $80.46 $399,609 - $567,967	-7,059 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$86.23 - $125.19 $150,471 - $218,456	1,745 Added 32.84%	7,059 $656,000
Q4 2020 Nov 19, 2021	SELL	$79.17 - $111.47 $3.69 Million - $5.2 Million	-46,614 Reduced 89.77%	5,314 $476,000
Q4 2020 Feb 18, 2021	BUY	$79.17 - $111.47 $3.78 Million - $5.33 Million	47,802 Added 1158.56%	51,928 $4.65 Million
Q3 2020 Nov 05, 2021	SELL	$81.91 - $134.94 $2.24 Million - $3.69 Million	-27,371 Reduced 86.9%	4,126 $426,000
Q3 2020 Nov 13, 2020	BUY	$81.91 - $134.94 $32,272 - $53,166	394 Added 1.27%	31,497 $3.25 Million
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $293,653 - $483,855	-5,405 Reduced 14.8%	31,103 $2.46 Million
Q1 2020 May 15, 2020	SELL	$49.34 - $68.76 $401,578 - $559,637	-8,139 Reduced 18.23%	36,508 $2.11 Million
Q4 2019 Feb 14, 2020	BUY	$51.21 - $59.06 $2.29 Million - $2.64 Million	44,647 New	44,647 $2.41 Million

Others Institutions Holding EBS

# of Institutions

194

Shares Held

39.4M

Call Options Held

399K

Put Options Held

157K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $640M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truist Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Truist Financial Corp with notifications on news.

Account

Truist Financial Corp Emergent Bio Solutions Inc. Transaction History